Pa. Court Won't Revive $20M Suit Over Skin Drug Patents
The Pennsylvania Superior Court refused Wednesday to revive claims leveled by five ex-pharmaceutical company shareholders alleging they stood to lose $20 million in payouts due to a mutual mistake in a...To view the full article, register now.
Already a subscriber? Click here to view full article